TY  - JOUR
AU  - Gilmore, Amanda K
AU  - Leone, Ruschelle M
AU  - Oesterle, Daniel W
AU  - Davis, Kelly Cue
AU  - Orchowski, Lindsay M
AU  - Ramakrishnan, Viswanathan
AU  - Kaysen, Debra
PY  - 2022
DA  - 2022/7/22
TI  - Web-Based Alcohol and Sexual Assault Prevention Program With Tailored Content Based on Gender and Sexual Orientation: Preliminary Outcomes and Usability Study of Positive Change (+Change)
JO  - JMIR Form Res
SP  - e23823
VL  - 6
IS  - 7
KW  - sexual assault prevention
KW  - alcohol
KW  - college students
KW  - sexual and gender minorities
AB  - Background: Alcohol use and sexual assault are common on college campuses in the United States, and the rates of occurrence differ based on gender identity and sexual orientation. Objective: We aimed to provide an assessment of the usability and preliminary outcomes of Positive Change (+Change), a program that provides integrated personalized feedback to target alcohol use, sexual assault victimization, sexual assault perpetration, and bystander intervention among cisgender heterosexual men, cisgender heterosexual women, and sexual minority men and women. Methods: Participants included 24 undergraduate students from a large university in the Southwestern United States aged between 18 and 25 years who engaged in heavy episodic drinking in the past month. All procedures were conducted on the web, and participants completed a baseline survey, +Change, and a follow-up survey immediately after completing +Change. Results: Our findings indicated that +Change was acceptable and usable among all participants, despite gender identity or sexual orientation. Furthermore, there were preliminary outcomes indicating the benefit for efficacy testing of +Change. Conclusions: Importantly, +Change is the first program to target alcohol use, sexual assault victimization, sexual assault perpetration, and bystander intervention within the same program and to provide personalized content based on gender identity and sexual orientation. Trial Registration: ClinicalTrials.gov NCT04089137; https://clinicaltrials.gov/ct2/show/NCT04089137 
SN  - 2561-326X
UR  - https://formative.jmir.org/2022/7/e23823
UR  - https://doi.org/10.2196/23823
UR  - http://www.ncbi.nlm.nih.gov/pubmed/35867393
DO  - 10.2196/23823
ID  - info:doi/10.2196/23823
ER  -